21 U.S. Code § 360n–1 - Priority review for qualified infectious disease products
2016—Pub. L. 114–255 designated existing provisions as subsec. (a), inserted heading, substituted “the first application” for “any application”, and added subsec. (b).
LII has no control over and does not endorse any external Internet site that contains links to or references LII.